Home / Stocks / MNPR

MNPR insider trading

Monopar Therapeutics — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
2
Bought · 24 mo
$130k
Buys · last 90 days
0 · $0
Most recent buy
2025-12-29

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-12-29Vu Quan Anh
Chief Financial Officer
Bought1,500$69.95$105k
2025-09-26Tactic Pharma LLC
Chief Executive Officer
Sold550,229$63.61$35.0M
2025-04-04Tactic Pharma LLC
Chief Executive Officer
Sold33,334$35.00$1.2M
2024-10-30Radhakrishnan Karthik
Chief Financial Officer
Bought1,550$16.25$25k

Most active insider buyers

InsiderRoleBuysTotal bought
Vu Quan AnhChief Financial Officer1$105k
Radhakrishnan KarthikChief Financial Officer1$25k

See MNPR on the chart

Every insider buy and sell for MNPR plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.